Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Palonosetron Hydrochloride: Precision 5-HT3 Receptor Anta...
2026-02-23
Palonosetron hydrochloride stands out as a next-generation, highly selective 5-HT3 receptor antagonist, enabling robust modeling of chemotherapy- and radiotherapy-induced nausea and vomiting (CINV/RINV) in preclinical and translational studies. Its unique allosteric binding and prolonged efficacy underpin advanced workflows for receptor and transporter assays, making it an indispensable tool for oncology and neuroscience research. Discover how APExBIO’s Palonosetron Hydrochloride (SKU B2229) elevates experimental rigor and clinical relevance.
Cisapride (R 51619): Precision Tool for Cardiac Electroph...
2026-02-23
Cisapride (R 51619) is a high-purity, nonselective 5-HT4 receptor agonist and potent hERG potassium channel inhibitor, pivotal for advanced cardiac electrophysiology and predictive cardiotoxicity research. Its robust solubility profile and validated use in iPSC-derived cardiomyocyte assays make it indispensable for high-throughput phenotypic screening and translational drug discovery.
Cimetidine (SKU B1557): Enhancing Reliability in Cell Via...
2026-02-22
This evidence-based article explores how Cimetidine (SKU B1557), a high-purity histamine-2 receptor antagonist from APExBIO, addresses persistent challenges in cell viability and blood-brain barrier (BBB) assays. Through scenario-driven Q&A, it guides researchers and lab technicians in optimizing workflow reproducibility, interpreting complex data, and selecting reliable reagents for demanding biomedical studies.
Perospirone (SM-9018 Free Base): Integrative Analysis of ...
2026-02-21
Explore how Perospirone (SM-9018 free base), a potent atypical antipsychotic agent for schizophrenia, uniquely bridges serotonergic/dopaminergic antagonism with Kv1.5 ion channel modulation. This article unveils underexplored mechanistic and translational insights for advanced neuropsychiatric disorder models.
Tropisetron Hydrochloride: Precision in Serotonin Recepto...
2026-02-20
Tropisetron Hydrochloride stands out as a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist, empowering researchers with validated IC50 potency and unmatched reliability for complex neuroscience and pharmacological studies. This article translates cutting-edge findings and practical workflows into actionable guidance, highlighting APExBIO’s quality leadership and troubleshooting expertise.
Clozapine N-oxide (CNO) in Chemogenetic Assays: Data-Back...
2026-02-20
This article addresses practical laboratory challenges faced by biomedical researchers and technicians when leveraging Clozapine N-oxide (CNO, SKU A3317) in cell viability, neuronal modulation, and chemogenetic workflows. Drawing on published data and real-world scenarios, it demonstrates how CNO enhances reproducibility, assay sensitivity, and experimental workflow safety in neuroscience research.
Palonosetron Hydrochloride (SKU B2229): Optimizing 5-HT3 ...
2026-02-19
This article addresses common pitfalls in cell-based 5-HT3 receptor and transporter inhibition assays, illustrating how Palonosetron Hydrochloride (SKU B2229) from APExBIO provides reproducible, highly selective inhibition and practical workflow advantages. Researchers will find scenario-driven guidance on protocol optimization, data interpretation, and product selection, ensuring experimental rigor for cancer research and beyond.
Escitalopram (SKU B1183): Reliable SSRI for Cell-Based As...
2026-02-19
This article provides scenario-driven guidance for biomedical researchers using Escitalopram (SKU B1183) in cell viability, proliferation, and cytotoxicity assays. Drawing on validated workflows and comparative data, it demonstrates how APExBIO’s high-purity, selective serotonin reuptake inhibitor supports reproducibility and sensitivity in depression and anxiolytic activity research.
Cisapride (R 51619): Deep Profiling for Cardiotoxicity an...
2026-02-18
Explore the multifaceted role of Cisapride, a nonselective 5-HT4 receptor agonist and hERG potassium channel inhibitor, in advanced cardiac electrophysiology and gastrointestinal motility studies. This article delivers a comprehensive scientific analysis, unique methodological insights, and strategic guidance for translational researchers.
Cimetidine as a Distinct H2R Modulator: Mechanistic Insig...
2026-02-18
Cimetidine, an established histamine-2 receptor antagonist with unique partial agonist activity, is redefining the landscape of translational research in gastrointestinal oncology and blood-brain barrier (BBB) modeling. This article bridges the gap between mechanistic pharmacology and practical bench-to-bedside applications, offering deep insights for researchers striving to unravel H2 receptor signaling, optimize experimental workflows, and advance reproducibility in high-impact studies. Drawing on recent model developments and comparative literature, we position APExBIO’s high-purity Cimetidine as an essential tool for the next generation of translational experiments.
Tropisetron Hydrochloride: Unlocking Precision in 5-HT3 R...
2026-02-17
Tropisetron Hydrochloride is a highly selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist, enabling reproducible, high-resolution studies of serotonin signaling and neurological disorder models. Its robust solubility and validated IC50 make it a gold standard for pharmacological and neuroscience workflows, with APExBIO’s stringent quality control ensuring consistent experimental performance.
Cisapride (R 51619): Next-Generation Strategies for Cardi...
2026-02-17
Explore how Cisapride (R 51619), a nonselective 5-HT4 receptor agonist and potent hERG potassium channel inhibitor, is redefining the translational research landscape. This thought-leadership piece fuses mechanistic insight with strategic guidance—examining deep learning-enabled phenotypic screening, iPSC-derived cardiomyocyte models, and the unique strengths of APExBIO’s high-purity offering—in order to accelerate discovery and de-risk preclinical pipelines.
Amitriptyline HCl in Neuropharmacology: Applied Workflows...
2026-02-16
Amitriptyline HCl stands out as a versatile serotonin/norepinephrine receptor inhibitor, empowering neuropharmacology and mood disorder research through robust receptor selectivity and solubility. Leverage its precise pharmacological profile for advanced CNS assay design, with troubleshooting strategies and workflow enhancements to maximize experimental reliability.
Mianserin Hydrochloride (SKU A1796): Data-Backed Solution...
2026-02-16
This article addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Mianserin Hydrochloride (SKU A1796) provides reliable, reproducible, and data-driven solutions for biomedical researchers. By grounding each scenario in practical lab workflows and literature benchmarks, we offer actionable strategies for assay optimization and compound selection.
Cimetidine: Distinct Histamine-2 Receptor Antagonist for ...
2026-02-15
Cimetidine is a histamine-2 receptor antagonist and partial H2 receptor agonist with a unique pharmacological profile. It is widely used in cancer research due to its antitumor activity in gastrointestinal malignancies. Its solubility, stability, and purity make it a robust reagent for investigating H2 receptor signaling and high-throughput drug screening.
8029 records 31/536 page Previous Next First page 上5页 3132333435 下5页 Last page